Robert W Postma - 02 Sep 2021 Form 4 Insider Report for ZIOPHARM ONCOLOGY INC (TCRT)

Role
Director
Signature
/s/ Courtney Thorne, Attorney-in-Fact
Issuer symbol
TCRT
Transactions as of
02 Sep 2021
Net transactions value
+$129,750
Form type
4
Filing time
03 Sep 2021, 17:22:06 UTC
Next filing
24 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Purchase $35,479 +20,508 +1.7% $1.73 1,201,870 02 Sep 2021 Direct F1
transaction TCRT Common Stock Purchase $94,271 +54,492 +1.3% $1.73 4,250,000 02 Sep 2021 See footnote F2
holding TCRT Common Stock 3,574 02 Sep 2021 By Spouse's IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 946,970 shares of common stock underlying the Units. The Reporting Person purchased 946,970 units of the Issuer (the "Units") for $2.64 per Unit in a private placement transaction with the Issuer. Each Unit consists of one share of common stock and a warrant to acquire one share of common stock.
F2 The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.